ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #4,479Hybrid

Journal of Diabetes and Its Complications

Acronym:jdc
•
Abbreviation (ISO):J DIABETES COMPLICAT
•
Identifier (ISSN):1056-8727(Print)/1873-460X(Online)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
3.2↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Diabetes and Its Complications

WoS Q3
12452.7920182.6820192.7820202.8520213.222022320232.920243.120253.22026
Annual Impact Factor Metric
Current (2026):3.2
Scopus SJR & RankScopus Q2
1.057
#4,479

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
108

108 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate3.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
205articles/year
28.13% Gold OA•95.45% Original Research

Aims & Scope

Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and researchers, that publishes original research about the pathogenesis, diagnosis and management of diabetes mellitus and its complications. JDC also publishes articles on physiological and molecular aspects of glucose homeostasis. The primary purpose of JDC is to act as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development, and promote better management of people with diabetes who are at risk for those complications. Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as well as epidemiology. Topics can range broadly from early prediabetes to late-stage complicated diabetes. Topics relevant to basic/translational reports include pancreatic islet dysfunction and insulin resistance, altered adipose tissue function in diabetes, altered neuronal control of glucose homeostasis and mechanisms of drug action. Topics relevant to diabetic complications include diabetic retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia.

Topics Covered (Recognized by AI)
Medicine99.8%Biology98.4%Endocrinology97.5%Diabetes mellitus95.7%Internal medicine88.9%Pathology59.3%Chemistry46.1%Biochemistry44.6%Type 2 diabetes43%Genetics37.6%Surgery31.6%Biotechnology31.5%Insulin30.9%Mathematics28.1%Psychology26.8%Statistics25.5%Radiology24.5%Physics20.7%Psychiatry20.6%Disease20.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q3
Rank103/198
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q2
Rank92/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.2
Articles / Year78
Total Citations34
2025
IF3.1
Articles / Year185
Total Citations498
2024
IF2.9
Articles / Year155
Total Citations878
2023
IF3
Articles / Year158
Total Citations1,385
2022
IF3.219
Articles / Year160
Total Citations2,014

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,479Scopus Q2SCImago Profile
Scopus Coverage:1992-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
1.057

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.10

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,341 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,393
3-Year Documents440
Citable Documents416

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ2
Endocrinology, Diabetes and MetabolismQ2
Internal MedicineQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Diabetes and Its Complications (acronym: jdc, abbr: J DIABETES COMPLICAT, ISSN: 1056-8727) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Inc. in United States since 1992. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.057 (Q2), an H-index of 108.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 205 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,341 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1992
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b3869f05-a335-4e3e-b99b-04c8757ae160
Database Updated: 2026-10-16